Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BIOS

BioPlus Acquisition (BIOS) Stock Price, News & Analysis

BioPlus Acquisition logo

About BioPlus Acquisition Stock (NASDAQ:BIOS)

Advanced Chart

Key Stats

Today's Range
$10.79
$10.80
50-Day Range
$10.75
$10.84
52-Week Range
$10.05
$11.68
Volume
5,636 shs
Average Volume
122,781 shs
Market Capitalization
$209.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BIOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPlus Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BIOS Stock News Headlines

PayMate Plans to Acquire DigiAsia Bios
AI Meltdown Imminent: Dump These Stocks Now!
If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.
See More Headlines

BIOS Stock Analysis - Frequently Asked Questions

BioPlus Acquisition (BIOS) raised $180 million in an initial public offering (IPO) on Friday, December 3rd 2021. The company issued 18,000,000 shares at a price of $10.00 per share. Cantor served as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioPlus Acquisition investors own include TransMedics Group (TMDX), Deciphera Pharmaceuticals (DCPH) and BioMarin Pharmaceutical (BMRN).

Company Calendar

Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:BIOS
CIK
1856653
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
19,370,000
Free Float
14,990,000
Market Cap
$209.10 million
Optionable
Not Optionable
Beta
0.01
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:BIOS) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners